latest news

The safety of GLP-1 receptor agonist drugs during pregnancy is a topic that should be discussed with a healthcare professional, as it involves a careful consideration of potential risks and benefits. Generally, there is limited information available on the use of GLP-1 receptor agonists in pregnant women, as pregnant individuals are often excluded from clinical trials. GLP-1 receptor agonists, such as exenatide, liraglutide, and dulaglutide, are commonly used in the management of type 2 diabetes. These drugs work by mimicking the action of glucagon-like peptide-1 (GLP-1), which helps regulate blood sugar levels. While they have been shown to be effective in controlling blood glucose in non-pregnant individuals, the effects on pregnancy and fetal development are not as well-studied. Pregnant individuals with diabetes need careful management of their blood sugar levels to prevent complications, both for themselves and their developing baby. It's important to consider the potential ...